CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing prevalence of animal diseases causing pain and inflammation
4.1.2. Increase in the number of veterinary practitioners and their income levels in developed
economies
4.1.3. Rising companion animal adoption
4.1.4. Increasing demand for pet insurance with growing animal health expenditure
4.2. Market Restraints & Challenges
4.2.1. Reduced awareness about animal healthcare
4.2.2. Increase in the cost of pet care
4.3. Market Opportunities
4.3.1. Growing popularity of non-conventional treatment techniques
4.3.2. Untapped emerging markets
CHAPTER 5. GLOBAL VETERINARY PAIN MANAGEMENT MARKET – BY
PRODUCT
5.1. Devices
5.1.1. Laser Therapy Devices
5.1.2. Electromagnetic Therapy Devices
5.2. Drugs
5.2.1. By Type
5.2.1.1. Nsaids
5.2.1.2. Opioids
5.2.1.3. Alpha-2 Agonists
5.2.1.4. Local Anesthetics
5.2.1.5. Disease-Modifying Osteoarthritis Drugs (DMOADS)
5.2.1.6. Others
5.2.2. By Route of Administration
5.2.2.1. Oral
5.2.2.2. Parenteral
5.2.2.3. Topical
CHAPTER 6. GLOBAL VETERINARY PAIN MANAGEMENT MARKET – BY
ANIMAL TYPE
6.1. Livestock
6.1.1. Cattle
6.1.2. Swine
6.1.3. Goats & Sheep
6.1.3. Others
6.2. Companion Animals
6.2.1. Dogs
6.2.2. Cats
6.2.3. Fish
6.2.4. Others
CHAPTER 7. GLOBAL VETERINARY PAIN MANAGEMENT MARKET – BY
DISTRIBUTION CHANNEL
7.1. Pharmacy
7.2. Veterinary hospitals and clinics
CHAPTER 8. GLOBAL VETERINARY PAIN MANAGEMENT MARKET - BY
APPLICATION
8.1. Postoperative Pain
8.2. Joint Pain
8.2.1 Osteoarthritis
8.2.2 Musculoskeletal Disorders
8.3. Cancer
8.4. Others
CHAPTER 9. GLOBAL VETERINARY PAIN MANAGEMENT MARKET - BY
GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.9. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.9. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.9. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL VETERINARY PAIN MANAGEMENT MARKET
COMPANY PROFILES
10.1. Merck Animal Health
10.2. Norbrook Laboratories
10.3. Dechra Pharmaceuticals
10.4. Boehringer Ingelheim
10.5. Bayer AG
10.6. Vetoquinol Pvt Ltd.
10.7. Zoetis, Inc.
10.8. Assisi Animal Health
10.9. Eli Lilly and Company
10.10. Chanelle Pharmaceuticals
10.11. K-Laser USA
10.12. Ceva Santé Animale S.A.
CHAPTER 11. GLOBAL VETERINARY PAIN MANAGEMENT MARKET -
COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
